nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralatrexate—DHFR—Mitotic G1-G1/S phases—CCND2—ocular cancer	0.00251	0.00251	CbGpPWpGaD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—HDAC1—ocular cancer	0.00251	0.00251	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN2C—ocular cancer	0.00246	0.00246	CbGpPWpGaD
Pralatrexate—DHFR—G1/S Transition—E2F1—ocular cancer	0.00245	0.00245	CbGpPWpGaD
Pralatrexate—DHFR—E2F transcription factor network—RB1—ocular cancer	0.00239	0.00239	CbGpPWpGaD
Pralatrexate—DHFR—Retinoblastoma (RB) in Cancer—CDK4—ocular cancer	0.00239	0.00239	CbGpPWpGaD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—CDKN2B—ocular cancer	0.00225	0.00225	CbGpPWpGaD
Pralatrexate—FPGS—Disease—E2F5—ocular cancer	0.00224	0.00224	CbGpPWpGaD
Pralatrexate—DHFR—Fluoropyrimidine Activity—TP53—ocular cancer	0.00221	0.00221	CbGpPWpGaD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—CDK2—ocular cancer	0.00221	0.00221	CbGpPWpGaD
Pralatrexate—FPGS—Disease—E2F4—ocular cancer	0.0022	0.0022	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN2C—ocular cancer	0.0022	0.0022	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—CCND2—ocular cancer	0.00219	0.00219	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—HDAC1—ocular cancer	0.00219	0.00219	CbGpPWpGaD
Pralatrexate—FPGS—Disease—RPL39—ocular cancer	0.00216	0.00216	CbGpPWpGaD
Pralatrexate—FPGS—Disease—RBL1—ocular cancer	0.00216	0.00216	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN2C—ocular cancer	0.00214	0.00214	CbGpPWpGaD
Pralatrexate—TYMS—G1/S Transition—E2F1—ocular cancer	0.00214	0.00214	CbGpPWpGaD
Pralatrexate—DHFR—G1/S Transition—CDK2—ocular cancer	0.00211	0.00211	CbGpPWpGaD
Pralatrexate—TYMS—E2F transcription factor network—RB1—ocular cancer	0.00209	0.00209	CbGpPWpGaD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—CDK4—ocular cancer	0.00209	0.00209	CbGpPWpGaD
Pralatrexate—DHFR—Retinoblastoma (RB) in Cancer—RB1—ocular cancer	0.00208	0.00208	CbGpPWpGaD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—E2F1—ocular cancer	0.00206	0.00206	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—TFDP1—ocular cancer	0.00204	0.00204	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—E2F5—ocular cancer	0.00204	0.00204	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.002	0.002	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—E2F4—ocular cancer	0.002	0.002	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—RBL1—ocular cancer	0.00196	0.00196	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—E2F2—ocular cancer	0.00196	0.00196	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—CDKN2B—ocular cancer	0.00196	0.00196	CbGpPWpGaD
Pralatrexate—TYMS—Fluoropyrimidine Activity—TP53—ocular cancer	0.00193	0.00193	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN2C—ocular cancer	0.00192	0.00192	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—GNA11—ocular cancer	0.0019	0.0019	CbGpPWpGaD
Pralatrexate—DHFR—E2F transcription factor network—CDKN1B—ocular cancer	0.00186	0.00186	CbGpPWpGaD
Pralatrexate—TYMS—G1/S Transition—CDK2—ocular cancer	0.00184	0.00184	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—E2F5—ocular cancer	0.00183	0.00183	CbGpPWpGaD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—RB1—ocular cancer	0.00181	0.00181	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—RBL2—ocular cancer	0.0018	0.0018	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—E2F1—ocular cancer	0.0018	0.0018	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—E2F4—ocular cancer	0.00179	0.00179	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—MYBL2—ocular cancer	0.00179	0.00179	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—E2F5—ocular cancer	0.00178	0.00178	CbGpPWpGaD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—CDK2—ocular cancer	0.00178	0.00178	CbGpPWpGaD
Pralatrexate—DHFR—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.00177	0.00177	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—GNAQ—ocular cancer	0.00177	0.00177	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—E2F2—ocular cancer	0.00176	0.00176	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—RBL1—ocular cancer	0.00176	0.00176	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—E2F4—ocular cancer	0.00175	0.00175	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.00175	0.00175	CbGpPWpGaD
Pralatrexate—FPGS—Disease—TFDP1—ocular cancer	0.00174	0.00174	CbGpPWpGaD
Pralatrexate—DHFR—G1/S Transition—RB1—ocular cancer	0.00174	0.00174	CbGpPWpGaD
Pralatrexate—DHFR—E2F transcription factor network—CDKN1A—ocular cancer	0.00172	0.00172	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—RBL1—ocular cancer	0.00171	0.00171	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—E2F2—ocular cancer	0.00171	0.00171	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—E2F3—ocular cancer	0.0017	0.0017	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.0017	0.0017	CbGpPWpGaD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—CDK4—ocular cancer	0.00168	0.00168	CbGpPWpGaD
Pralatrexate—DHFR—E2F transcription factor network—EP300—ocular cancer	0.00163	0.00163	CbGpPWpGaD
Pralatrexate—TYMS—E2F transcription factor network—CDKN1B—ocular cancer	0.00162	0.00162	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MAML2—ocular cancer	0.00162	0.00162	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.00162	0.00162	CbGpPWpGaD
Pralatrexate—DHFR—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.00162	0.00162	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—RBL2—ocular cancer	0.00161	0.00161	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—E2F5—ocular cancer	0.00159	0.00159	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—HDAC1—ocular cancer	0.00159	0.00159	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.00158	0.00158	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—RBL2—ocular cancer	0.00157	0.00157	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—E2F4—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—MYBL2—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—CDK2—ocular cancer	0.00155	0.00155	CbGpPWpGaD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.00155	0.00155	CbGpPWpGaD
Pralatrexate—DHFR—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.00154	0.00154	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—RBL1—ocular cancer	0.00153	0.00153	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—E2F2—ocular cancer	0.00153	0.00153	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—RBBP4—ocular cancer	0.00152	0.00152	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—E2F3—ocular cancer	0.00152	0.00152	CbGpPWpGaD
Pralatrexate—TYMS—G1/S Transition—RB1—ocular cancer	0.00151	0.00151	CbGpPWpGaD
Pralatrexate—TYMS—E2F transcription factor network—CDKN1A—ocular cancer	0.0015	0.0015	CbGpPWpGaD
Pralatrexate—DHFR—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.00149	0.00149	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—E2F3—ocular cancer	0.00149	0.00149	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.00149	0.00149	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00149	0.00149	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—CDK4—ocular cancer	0.00147	0.00147	CbGpPWpGaD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—RB1—ocular cancer	0.00146	0.00146	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDC25A—ocular cancer	0.00145	0.00145	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CCND3—ocular cancer	0.00144	0.00144	CbGpPWpGaD
Pralatrexate—TYMS—E2F transcription factor network—EP300—ocular cancer	0.00143	0.00143	CbGpPWpGaD
Pralatrexate—DHFR—E2F transcription factor network—MYC—ocular cancer	0.00142	0.00142	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—TFDP1—ocular cancer	0.00142	0.00142	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.00141	0.00141	CbGpPWpGaD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.00141	0.00141	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—RBL2—ocular cancer	0.00141	0.00141	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.00138	0.00138	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MAML2—ocular cancer	0.00138	0.00138	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00136	0.00136	CbGpPWpGaD
Pralatrexate—DHFR—G1/S Transition—CDKN1B—ocular cancer	0.00135	0.00135	CbGpPWpGaD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.00135	0.00135	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PSPH—ocular cancer	0.00134	0.00134	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—E2F3—ocular cancer	0.00133	0.00133	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—RBBP4—ocular cancer	0.00133	0.00133	CbGpPWpGaD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.0013	0.0013	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CCND3—ocular cancer	0.00128	0.00128	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—RB1—ocular cancer	0.00128	0.00128	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—TP53—ocular cancer	0.00127	0.00127	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDC25A—ocular cancer	0.00126	0.00126	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CCND3—ocular cancer	0.00125	0.00125	CbGpPWpGaD
Pralatrexate—DHFR—G1/S Transition—CDKN1A—ocular cancer	0.00125	0.00125	CbGpPWpGaD
Pralatrexate—TYMS—E2F transcription factor network—MYC—ocular cancer	0.00124	0.00124	CbGpPWpGaD
Pralatrexate—DHFR—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.00124	0.00124	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—TFDP1—ocular cancer	0.00124	0.00124	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—HDAC1—ocular cancer	0.00119	0.00119	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—GNA11—ocular cancer	0.00119	0.00119	CbGpPWpGaD
Pralatrexate—TYMS—G1/S Transition—CDKN1B—ocular cancer	0.00118	0.00118	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00118	0.00118	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PSPH—ocular cancer	0.00117	0.00117	CbGpPWpGaD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.00114	0.00114	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CCND3—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00111	0.00111	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—GNAQ—ocular cancer	0.0011	0.0011	CbGpPWpGaD
Pralatrexate—TYMS—G1/S Transition—CDKN1A—ocular cancer	0.00109	0.00109	CbGpPWpGaD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.00109	0.00109	CbGpPWpGaD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.00108	0.00108	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDK6—ocular cancer	0.00107	0.00107	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—CDK4—ocular cancer	0.00107	0.00107	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CDKN2B—ocular cancer	0.00106	0.00106	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SAG—ocular cancer	0.00106	0.00106	CbGpPWpGaD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.00105	0.00105	CbGpPWpGaD
Pralatrexate—DHFR—G1/S Transition—MYC—ocular cancer	0.00103	0.00103	CbGpPWpGaD
Pralatrexate—DHFR—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.00102	0.00102	CbGpPWpGaD
Pralatrexate—FPGS—Disease—HDAC1—ocular cancer	0.00101	0.00101	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—GNA11—ocular cancer	0.00101	0.00101	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.000993	0.000993	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDK6—ocular cancer	0.000956	0.000956	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.000948	0.000948	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—GNAQ—ocular cancer	0.000938	0.000938	CbGpPWpGaD
Pralatrexate—DHFR—Disease—E2F5—ocular cancer	0.000938	0.000938	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDK6—ocular cancer	0.000933	0.000933	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.000919	0.000919	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CCND2—ocular cancer	0.000919	0.000919	CbGpPWpGaD
Pralatrexate—DHFR—Disease—E2F4—ocular cancer	0.000919	0.000919	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.000917	0.000917	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CDKN2B—ocular cancer	0.000905	0.000905	CbGpPWpGaD
Pralatrexate—TYMS—G1/S Transition—MYC—ocular cancer	0.000902	0.000902	CbGpPWpGaD
Pralatrexate—DHFR—Disease—RBL1—ocular cancer	0.000901	0.000901	CbGpPWpGaD
Pralatrexate—DHFR—Disease—RPL39—ocular cancer	0.000901	0.000901	CbGpPWpGaD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.000887	0.000887	CbGpPWpGaD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—MYC—ocular cancer	0.000871	0.000871	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDK6—ocular cancer	0.000834	0.000834	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000824	0.000824	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000824	0.000824	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CCND2—ocular cancer	0.000822	0.000822	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—HDAC1—ocular cancer	0.000822	0.000822	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CCND2—ocular cancer	0.000802	0.000802	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.000802	0.000802	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—MYC—ocular cancer	0.00076	0.00076	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000757	0.000757	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000752	0.000752	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN2B—ocular cancer	0.000737	0.000737	CbGpPWpGaD
Pralatrexate—DHFR—Disease—TFDP1—ocular cancer	0.000726	0.000726	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000719	0.000719	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000718	0.000718	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CCND2—ocular cancer	0.000717	0.000717	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—HDAC1—ocular cancer	0.000717	0.000717	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000694	0.000694	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—E2F1—ocular cancer	0.000676	0.000676	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000661	0.000661	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—E2F1—ocular cancer	0.00066	0.00066	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000653	0.000653	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN2B—ocular cancer	0.000643	0.000643	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—EP300—ocular cancer	0.000634	0.000634	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000617	0.000617	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MDM2—ocular cancer	0.00059	0.00059	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—E2F1—ocular cancer	0.00059	0.00059	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDK2—ocular cancer	0.000583	0.000583	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MAML2—ocular cancer	0.000577	0.000577	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000576	0.000576	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000574	0.000574	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000569	0.000569	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDK4—ocular cancer	0.000551	0.000551	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CDKN1B—ocular cancer	0.000539	0.000539	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000538	0.000538	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—RB1—ocular cancer	0.000536	0.000536	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDK2—ocular cancer	0.000509	0.000509	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MDM2—ocular cancer	0.000502	0.000502	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CDKN1A—ocular cancer	0.000498	0.000498	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDK4—ocular cancer	0.000481	0.000481	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—RB1—ocular cancer	0.000479	0.000479	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—EP300—ocular cancer	0.000473	0.000473	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000473	0.000473	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—RB1—ocular cancer	0.000468	0.000468	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CDKN1B—ocular cancer	0.000458	0.000458	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—TP53—ocular cancer	0.000454	0.000454	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CDKN1A—ocular cancer	0.000423	0.000423	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HDAC1—ocular cancer	0.000422	0.000422	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GNA11—ocular cancer	0.000422	0.000422	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—RB1—ocular cancer	0.000418	0.000418	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000417	0.000417	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MYC—ocular cancer	0.000413	0.000413	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—TGFB1—ocular cancer	0.000412	0.000412	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—MDM2—ocular cancer	0.000409	0.000409	CbGpPWpGaD
Pralatrexate—FPGS—Disease—EP300—ocular cancer	0.000403	0.000403	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000399	0.000399	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000398	0.000398	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—EP300—ocular cancer	0.000396	0.000396	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GNAQ—ocular cancer	0.000392	0.000392	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000385	0.000385	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CDKN2B—ocular cancer	0.000378	0.000378	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN1B—ocular cancer	0.000373	0.000373	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GNA11—ocular cancer	0.000368	0.000368	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—EP300—ocular cancer	0.000367	0.000367	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000364	0.000364	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—MDM2—ocular cancer	0.000357	0.000357	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CCND1—ocular cancer	0.000356	0.000356	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MYC—ocular cancer	0.000351	0.000351	CbGpPWpGaD
Pralatrexate—FPGS—Disease—TGFB1—ocular cancer	0.00035	0.00035	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000348	0.000348	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN1A—ocular cancer	0.000344	0.000344	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GNAQ—ocular cancer	0.000342	0.000342	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—EP300—ocular cancer	0.000337	0.000337	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000336	0.000336	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—EP300—ocular cancer	0.000328	0.000328	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN1B—ocular cancer	0.000326	0.000326	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—HRAS—ocular cancer	0.000324	0.000324	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—EP300—ocular cancer	0.00032	0.00032	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—MYC—ocular cancer	0.000319	0.000319	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CCND1—ocular cancer	0.000311	0.000311	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN1A—ocular cancer	0.000301	0.000301	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—AKT1—ocular cancer	0.000286	0.000286	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—EP300—ocular cancer	0.000286	0.000286	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—MYC—ocular cancer	0.000286	0.000286	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—MYC—ocular cancer	0.000279	0.000279	CbGpPWpGaD
Pralatrexate—FPGS—Disease—HRAS—ocular cancer	0.000275	0.000275	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—MYC—ocular cancer	0.000249	0.000249	CbGpPWpGaD
Pralatrexate—FPGS—Disease—AKT1—ocular cancer	0.000243	0.000243	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—AKT1—ocular cancer	0.00024	0.00024	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—TP53—ocular cancer	0.000235	0.000235	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MDM2—ocular cancer	0.00021	0.00021	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—TP53—ocular cancer	0.000205	0.000205	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—AKT1—ocular cancer	0.000204	0.000204	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CDKN1B—ocular cancer	0.000191	0.000191	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CDKN1A—ocular cancer	0.000177	0.000177	CbGpPWpGaD
Pralatrexate—DHFR—Disease—EP300—ocular cancer	0.000168	0.000168	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MYC—ocular cancer	0.000147	0.000147	CbGpPWpGaD
Pralatrexate—DHFR—Disease—TGFB1—ocular cancer	0.000146	0.000146	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—EP300—ocular cancer	0.000141	0.000141	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—EP300—ocular cancer	0.000123	0.000123	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HRAS—ocular cancer	0.000115	0.000115	CbGpPWpGaD
Pralatrexate—DHFR—Disease—AKT1—ocular cancer	0.000102	0.000102	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—AKT1—ocular cancer	8.51e-05	8.51e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—AKT1—ocular cancer	7.43e-05	7.43e-05	CbGpPWpGaD
